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	 A	 series	 of	 2,3‐dihydro‐2‐(susbtituted)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐benzothiazepines
(4a‐v)	 have	 been	 synthesized	 evaluated	 for	 their	 in	 vitro	 cytotoxicity	 and	 antimicrobial
activities.	 Among	 the	 tested	 compounds	 for	 cytotoxicity	 using	 Brine	 shrimp	 lethality	 assay,
compound	4q	exhibited	significant	cytotoxicity	at	ED50	values	3.45±0.15	µg/mL.	This	level	of
activity	was	found	comparable	to	that	of	the	reference	drug	podophyllotoxin	with	ED50	value
3.61±0.17	µg/mL.	Antimicrobial	activity	was	assessed	using	agar	well	diffusion	assay	method
against	 selected	 Gram‐positive,	 Gram‐negative	 and	 fungal	 strains.	 Among	 the	 compounds
tested,	4q,	4r	and	4l	were	found	to	be	more	active	with	MIC	16‐32	µg/mL	against	all	tested
microorganisms.	
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1.	Introduction	
	
1,5‐Benzothiazepines	 are	 important	 nitrogen‐	 and	 sulfur‐
containing	 seven‐membered	 heterocyclic	 compounds	 in	 drug	
research	 since	 they	 possess	 diverse	 bioactivities.	 1,5‐
Benzothiazepines	 are	 the	most	well‐known	 representatives	 of	
benzologs	 of	 1,4‐thiazepine	 and	 one	 of	 the	 three	 possible	
benzo‐condensed	 derivatives,	 viz.	 1,4‐benzothiazepines,	 4,1‐
benzothiazepines	and	1,5‐benzothiazepines	[1].	The	1,5‐benzo‐
thiazepine	 derivatives	 are	 of	 particular	 interest	 for	 lead	
discovery	because	they	have	been	found	active	against	different	
families	 of	 targets	 [2].	 The	 first	 molecule	 of	 1,5‐benzo‐
thiazepine	 used	 clinically	 was	 diltiazem,	 followed	 by	
clentiazem,	 for	 their	 cardiovascular	 action.	 Some	 of	 the	 1,5‐
benzothiazepine	 derivatives	were	 also	 used	 clinically	 for	 CNS	
disorders,	which	includes	thiazesim,	clothiapine	and	quetiapine	
[3].	Therefore,	the	1,5‐benzothiazepines	are	useful	compounds	
in	the	drug	research	that	has	stimulated	the	invention	of	a	wide	
range	of	synthetic	methods	for	their	preparation	and	chemical	
transformations	[4].	The	common	strategy	for	the	construction	
of	 the	1,5‐benzothiazepine	moiety	 is	 the	 reaction	of	1,3‐diaryl	
prop‐2‐enones	 with	 o‐aminothiophenol	 [5].	 The	 various	
reported	 methodologies	 involve	 the	 use	 of	 inorganic	 solid	
supports	such	as	alumina,	silica	gel	and	clay	under	microwave	
irradiation,	acetic	acid	or	trifluoroacetic	acid,	hydrochloric	acid,	
piperidine	etc.	[6].		
The	 importance	 of	 the	 1,5‐benzothiazepine	 nucleus	 has	
been	 well	 established	 as	 illustrated	 by	 a	 large	 number	 of	
compounds	 which	 have	 been	 patented	 as	 chemotherapeutic	
agents	 [7].	 A	 number	 of	 biological	 activities	 have	 also	 been	
associated	with	it,	such	as	antianginal	[8],	antihypertensive	[9],	
antiischemic	 [10],	 antiarrhythmic	 [11],	 platelet	 aggregation	
inhibitor	 [12],	 vasodilator	 [13],	 calcium	 channel	 blocker	 [14],	
calcium	channel	antagonist	[15]	and	calcium	channel	activator	
[16].	In	recent	past,	under	the	frame	work	of	“Green	Chemistry”	
microwave‐assisted	 synthesis	 is	 one	 of	 the	 non‐conventional	
techniques	 used	 in	 laboratory	 for	 the	 synthesis	 of	 organic	
compounds.	 This	 is	 an	 eco‐friendly	 technology	 and	 helps	 to	
prevent	 pollution	 [17].	 Therefore	 we	 are	 interested	 in	
developing	 a	 rapid,	 microwave‐assisted	 protocol	 towards	 the	
preparation	 of	 1,5‐benzothiazepines	 from	 2‐aminothiophenol	
and	 various	 chalcone	 derivatives	 in	 the	 presence	 of	 catalytic	
amount	 of	 piperidine,	 acetic	 acid	 using	 DMF	 as	 a	 reaction	
mediator	[18].	The	chemical	structures	of	the	compounds	were	
proved	by	analytical	and	spectral	data.		
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Scheme	1
	
	
The	 newly	 synthesized	 compounds,	 which	 earlier	 not	
reported	 were	 evaluated	 for	 their	 in	 vitro	 cytotoxic	 and	
antimicrobial	properties.	
	
2.	Experimental	 	
	
2.1.	Instrumentation	
	
Melting	points	were	 taken	 in	open	capillary	 tubes	and	are	
therefore	 uncorrected.	 Purity	 of	 the	 compounds	was	 checked	
on	silica	gel	G	TLC	plates	of	2	mm	thickness	using	n‐hexane	and	
ethyl	 acetate	 as	 solvent	 system.	The	 visualization	 of	 spot	was	
carried	 out	 in	 an	 iodine	 chamber.	 The	 FT‐IR	 spectra	 were	
recorded	 on	Perkin‐Elmer	 spectrometer.	 The	 1H	NMR	 spectra	
were	 scanned	 on	 a	 Bruker	 400	 MHz	 spectrometer	 in	 CDCl3	
using	 TMS	 as	 internal	 standard	 and	 chemical	 shifts	 are	
expressed	in	δ,	ppm.	The	ESI	mass	spectra	were	recorded	on	an	
Agilent	6100	QQQ	spectrometer	(positive	ion	mode).	Reactions	
were	 carried	 out	 in	 a	 Catalyst	 Scientific	 Microwave	 Oven,	
Model:	 CATA	 2R,	 Range:	 140‐700	 W,	 Make:	 Catalyst	 System,	
Pune,	India.	
	
2.2.	General	procedure	for	the	synthesis	of	1,5‐benzo	
thiazepines	(4a‐4v)	
	
The	 reaction	 order	 proposed	 for	 the	 preparation	 of	 title	
compounds	 (4a‐v)	 is	 shown	 in	 Scheme	 1.	 The	 principal	
intermediates	 in	 the	 present	 study	 (3a‐v)	 were	 prepared	 by	
using	standard	Claisen‐Schmidt	condensation	reaction	between	
2‐acetyl‐1‐methylpyrrole	(1)	and	appropriate	aromatic/hetero	
aromatic	aldehydes	 (2a‐v)in	 the	presence	of	100%	potassium	
hydroxide	solution	in	ethanol	afforded	a	series	of	1‐(1‐methyl‐
1H‐pyrrol‐2‐yl)‐3‐(substituted)‐2‐propen‐1‐ones	 (3a‐v)	 in	
good	 yield.	 Subsequent	 condensation	 reaction	 of	 crude	
chalcone	 derivatives	 (3a‐v)	 and	 2‐aminothiophenol	 with	
catalytic	 amount	 of	 acetic	 acid	 and	 piperidine	 in	 dimethyl	
formamide	(DMF)	was	taken	in	a	conical	 flask	and	placed	in	a	
microwave	 oven	 and	 irradiated	 for	 3‐5	 min.	 Then	 reaction	
mixture	was	cooled	to	room	temperature	and	treated	with	cold	
water.	 The	 solid	 separated	 was	 isolated	 by	 simple	 Buchner	
filtration;	 final	 purification	 was	 achieved	 by	 recrystallization	
from	 ethanol	 to	 give	 corresponding	 2,3‐dihydro‐2‐
(susbtituted)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐benzothiaze‐
pines	(4a‐v)	in	good	yield[19].	
2,3‐Dihydro‐2‐(phenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐
benzothiazepine	(4a):	Colour:	Yellow.	Yield:	86%.	M.p.:	125‐127	
oC.	FT‐IR	(KBr,	vmax,	cm‐1):	1596	(C=N),	1510	(C=C),	1365	(C‐N),	
688	 (C‐S).	 1H	 NMR	 (400	 MHz,	 CDCl3,	 δ,	 ppm):2.50	 (3H,	 s,	 N‐
CH3),	3.36	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	3.43	(dd,	J3a,3b	=	
14.4	Hz,	J3a,2	=	9.6	Hz,	1H,	C3‐H‐3a),	4.89	(dd,J2,3a	=	5.1	Hz,	J2,3b	=	
12	Hz,	 1H,	 C2‐H),	 6.95‐7.60	 (7H,	m,	 Ar‐H),	 7.12	 (1H,	 s,	 Ar‐H),	
7.72	 (4H,	 m,	 Ar‐H).	 ESI‐MS	 (m/z):	 319	 [M+H]+.	 Anal.	 calcd.	
forC20H18N2S:	C,	75.44;	H,	5.70;	N,	8.80.	Found:	C,	75.41;	H,	5.73;	
N,	8.82%.	
2,3‐Dihydro‐2‐(4‐methylphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐
yl)‐1,5‐benzothiazepine	 (4b):	Colour:	Yellow.	Yield:	89%.	 	M.p.:	
141‐143	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1585	 (C=N),	 1505	 (C=C),	
1395	(C‐N),	654	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	2.40	
(3H,	s,	Ar‐CH3),	2.45	(3H,	s,	N‐CH3),	3.04	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	
1H,	C3‐H‐3b),	3.25	 (dd,	 J3a,3b	=	14.4	Hz,	 J3a,2	=	9.9	Hz,	1H,	C3‐H‐
3a),	 4.94	 (dd,	 J2,3a	 =	 5.1	Hz,	 J2,3b	 =	 12	Hz,	 1H,	 C2‐H),	 7.10‐7.33	
(6H,	m,	 Ar‐H),	 7.45	 (1H,	 s,	 Ar‐H),	 7.61	 (4H,	m,	 Ar‐H).	 ESI‐MS	
(m/z):	333	[M+H]+.	Anal.	calcd.	for	C21H20N2S:	C,	75.87;	H,	6.06;	
N,	8.43.	Found:	C,	75.85;	H,	6.02;	N,	8.41%.	
2,3‐Dihydro‐2‐(4‐dimethylaminophenyl)‐4‐(1‐methyl‐1H‐
pyrrol‐2‐yl)‐1,5‐benzothiazepine	 (4c):	 Colour:	 Yellow.	 Yield:	
88%.	 M.p.:	 115‐117	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1608	 (C=N),	
1509	(C=C),	1390	(C‐N),	679	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	2.43	(3H,	s,	N‐CH3),	3.20	(6H,	s,	N‐(CH3)2,	3.26	(t,	J3b,3a	=	
J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	3.83	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.2	
Hz,	1H,	C3‐H‐3a),	4.96	(dd,	J2,3a	=	5.3	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	
6.70‐7.20	(4H,	m,	Ar‐H),	7.29	(1H,	s,	Ar‐H),	7.45	(6H,	m,	Ar‐H).	
ESI‐MS	(m/z):	362	[M+H]+.	Anal.	calcd.	for	C22H23N3S:	C,	73.09;	
H,	6.41;	N,	11.62.	Found:	C,	73.04;	H,	6.42;	N,	11.61%.	
2,3‐Dihydro‐2‐(3‐methoxyphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐
yl)‐1,5‐benzothiazepine	 (4d):	 Colour:	 Yellow.	 Yield:	 75%.	M.p.:	
137‐139	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1612	 (C=N),	 1501(C=C),	
1382	(C‐N),	689	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	2.80	
(3H,	s,	N‐CH3),	2.87	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	3.36	
(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.9	Hz,	1H,	C3‐H‐3a),	3.82	(3H,	s,	Ar‐
OCH3),	5.31	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.08	(1H,	s,	
Ar‐H),	 7.30	 (3H,	 m,	 Ar‐H),	 6.98‐8.12	 (7H,	 m,	 Ar‐H).	 ESI‐MS	
(m/z):	 349	 [M+H]+.	 Anal.	 calcd.	 for	 C21H20N2OS:	 C,	 72.38;	 H,	
5.79;	N,	8.04.	Found:	C,	72.35;	H,	5.75;	N,	8.03%.	
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2,3‐Dihydro‐2‐(3,4‐dimethoxyphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐
2‐yl)‐1,5‐benzothiazepine	 (4e):	 Colour:	 Yellow.	 Yield:	 79%.		
M.p.:	 143‐145	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1588	 (C=N),	 1505	
(C=C),	1382	(C‐N),	1187	(O‐CH3),	656	(C‐S).	1H	NMR	(400	MHz,	
CDCl3,	δ,	ppm):	2.40	(3H,	s,	N‐CH3),	3.51	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	
1H,	C3‐H‐3b),	3.74	(dd,	 J3a,3b	=	14.4	Hz,	 J3a,2	=	9.9	Hz,	1H,	C3‐H‐
3a),	3.88	(6H,	s,	Ar‐OCH3),	4.32	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	
1H,	C2‐H),	7.09	(1H,	s,	Ar‐H),	7.12	(3H,	m,	Ar‐H),	6.98‐8.10	(6H,	
m,	 Ar‐H).	 ESI‐MS	 (m/z):	 379	 [M+H]+.	 Anal.	 calcd.	 for	
C22H22N2O2S:	C,	69.81;	H,	5.86;	N,	7.40.	Found:	C,	69.88;	H,	5.82;	
N,	7.41%.	
2,3‐Dihydro‐2‐(3,4,5‐trimethoxyphenyl)‐4‐(1‐methyl‐1H‐
pyrrol‐2‐yl)‐1,5‐benzothiazepine	 (4f):	 Colour:	 Yellow.	 Yield:	
85%.	 M.p.:	 149‐151	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1648	 (C=N),	
1505	(C=C),	1365	(C‐N),	1225	(O‐CH3),	678	(C‐S).	1H	NMR	(400	
MHz,	CDCl3,	δ,	ppm):	2.00	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	
2.45	(3H,	s,	N‐CH3),	2.83	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.9	Hz,	1H,	
C3‐H‐3a),	 3.06	 (dd,	 J2,3a	 =	 5.3	Hz,	 J2,3b	 =	 12	Hz,	 1H,	 C2‐H),	 3.70	
(3H,	 s,	 Ar‐OCH3),	 3.88	 (6H,	 s,	2×Ar‐OCH3),	 6.60	 (4H,	m,	Ar‐H),	
7.22	(1H,	s,	Ar‐H),	7.30‐7.50	(4H,	m,	Ar‐H).	ESI‐MS	(m/z):	409	
[M+H]+.	Anal.	calcd.	for	C23H24N2O3S:	C,	67.62;	H,	5.92;	N,	6.86.	
Found:	C,	67.65;	H,	5.91;	N,	6.83%.	
2,3‐Dihydro‐2‐(2‐hydroxyphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐
yl)‐1,5‐benzothiazepine	 (4g):	 Colour:	 Yellow.	 Yield:	 77%.	M.p.:	
227‐229	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 3555	 (O‐H),	 1653	 (C=N),	
1528	(C‐N),	1502	(C=C),	691	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	2.41	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	2.68	(3H,	s,	N‐
CH3),	3.34	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.0	Hz,	1H,	C3‐H‐3a),	3.85	
(dd,	 J2,3a	 =	5.1	Hz,	 J2,3b	 =	12	Hz,	1H,	C2‐H),	6.85	 (1H,	s,	Ar‐OH),	
7.25	(1H,	s,	Ar‐H),	7.30	(3H,	m,	Ar‐H),	7.15‐7.80	(7H,	m,	Ar‐H).	
ESI‐MS	(m/z):	335	[M+H]+.	Anal.	calcd.	for	C20H18N2OS:	C,	71.83;	
H,	5.42;	N,	8.38.	Found:	C,	71.81;	H,	5.45;	N,	8.32%.	
2,3‐Dihydro‐2‐(4‐hydroxyphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐
yl)‐1,5‐benzothiazepine	 (4h):	 Colour:	 Yellow.	 Yield:	 71%.	M.p.:	
238‐240	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 3411	 (O‐H),	 1653	 (C=N),	
1528	(C‐N),	1502	(C=C),	697	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	2.21	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	2.34	(3H,	s,	N‐
CH3),	3.24	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.0	Hz,	1H,	C3‐H‐3a),	3.82	
(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.21	(1H,	s,	Ar‐H),	7.37	
(3H,	m,	Ar‐H),	7.11‐7.88	(7H,	m,	Ar‐H),	7.99	(1H,	s,	Ar‐OH).	ESI‐
MS	(m/z):	335	[M+H]+.	Anal.	calcd.	for	C20H18N2OS:	C,	71.83;	H,	
5.42;	N,	8.38.	Found:	C,	71.81;	H,	5.43;	N,	8.39%.	
2,3‐Dihydro‐2‐(3‐methoxy‐4‐hydroxyphenyl)‐4‐(1‐methyl‐
1H‐pyrrol‐2‐yl)‐1,5‐benzothiazepine	 (4i):	 Colour:	 Yellow.	 Yield:	
79%.	 M.p.:	 152‐154	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 3540	 (O‐H),	
1598	(C=N),	1502	(C=C),	1378	(C‐N),	1234	(O‐CH3),	688	(C‐S).	
1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	1.03	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	
1H,	C3‐H‐3b),	2.48	(3H,	s,	N‐CH3),	2.50	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	
9.4	Hz,	1H,	C3‐H‐3a),	3.43	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐
H),	 3.80	 (3H,	 s,	 Ar‐O‐CH3),6.85	 (4H,	m,	 Ar‐H),	 6.95	 (2H,	 s,	 Ar‐
OH),	7.20	(2H,	s,	Ar‐H),	7.35‐7.90	(3H,	m,	Ar‐H).	ESI‐MS	(m/z):	
365	 [M+H]+.	Anal.	 calcd.	 for	C21H20N2O2S:	 C,	 69.20;	H,	 5.53;	N,	
7.69.	Found:	C,	69.24;	H,	5.51;	N,	7.68%.	
2,3‐Dihydro‐2‐(3‐nitrophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4j):	Colour:	Yellow.	Yield:	82%.	M.p.:	143‐
145	oC.	FT‐IR	(KBr,	vmax,	cm‐1):	1580	(C=N),	1522	(N=O),	1501	
(C=C),	1385	 (C‐N),	1345	(N=O),	689	(C‐S).	 1H	NMR	(400	MHz,	
CDCl3,	δ,	ppm):	2.70	(3H,	s,	N‐CH3),	2.86	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	
1H,	C3‐H‐3b),	3.38	(dd,	 J3a,3b	=	14.4	Hz,	 J3a,2	=	9.6	Hz,	1H,	C3‐H‐
3a),	5.42	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.30	(1H,	s,	
Ar‐H),	 7.80	 (3H,	 m,	 Ar‐H),	 7.98‐8.60	 (7H,	 m,	 Ar‐H).	 ESI‐MS	
(m/z):	 364	 [M+H]+.	 Anal.	 calcd.	 for	 C20H17N3O2S:	 C,	 66.10;	 H,	
4.71;	N,	11.56.	Found:	C,	66.16;	H,	4.74;	N,	11.52%.	
2,3‐Dihydro‐2‐(4‐nitrophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4k):	Colour:	Yellow.	Yield:	71%.	M.p.:	129‐
131	oC.	FT‐IR	(KBr,	vmax,	cm‐1):	1586	(C=N),	1515	(N=O),	1506	
(C=C),	1380	 (C‐N),	1338	(N=O),	713	(C‐S).	 1H	NMR	(400	MHz,	
CDCl3,	δ,	ppm):	2.58	(3H,	s,	N‐CH3),	3.10	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	
1H,	C3‐H‐3b),	3.47	(dd,	 J3a,3b	=	14.4	Hz,	 J3a,2	=	9.7	Hz,	1H,	C3‐H‐
3a),	5.42	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.18	(1H,	s,	
Ar‐H),	 7.25	 (3H,	 m,	 Ar‐H),	 7.65‐8.20	 (7H,	 m,	 Ar‐H).	 ESI‐MS	
(m/z):	 364	 [M+H]+.	 Anal.	 calcd.	 for	 C20H17N3O2S:	 C,	 66.10;	 H,	
4.71;	N,	11.56.	Found:	C,	66.12;	H,	4.72;	N,	11.53%.	
2,3‐Dihydro‐2‐(4‐fluorophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4l):	Colour:	Yellow.	Yield:	92%.	M.p.:	152‐
154	 oC.	FT‐IR	 (KBr,	vmax,	 cm‐1):	1625	 (C=N),	1509	 (C=C),	1399	
(C‐N),	689	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	2.45	(3H,	s,	
N‐CH3),	2.97	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	3.50	(dd,	J3a,3b	
=	14.4	Hz,	J3a,2	=	9.6	Hz,	1H,	C3‐H‐3a),	5.27	(dd,	J2,3a	=	5.1	Hz,	J2,3b	
=	12	Hz,	1H,	C2‐H),	7.05	(1H,	s,	Ar‐H),	7.19	(3H,	m,	Ar‐H),	7.20‐
8.09	(7H,	m,	Ar‐H).	ESI‐MS	(m/z):	337	[M+H]+.	Anal.	calcd.	 for	
C20H17FN2S:	C,	71.40;	H,	5.09;	N,	8.33.	Found:	C,	71.41;	H,	5.07;	
N,	8.35%.	
2,3‐Dihydro‐2‐(4‐chlorophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	 (4m):	 Colour:	 Yellow.	 Yield:	 87%.	 	 M.p.:	
162‐164	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1595	 (C=N),	 1502	 (C=C),	
1384	(C‐N),	778	(C‐Cl),	667	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	2.40	(3H,	s,	N‐CH3),	3.39	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐
H‐3b),	3.53	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.9	Hz,	1H,	C3‐H‐3a),	5.0	
(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.22‐8.08	(7H,	m,	Ar‐
H),	 7.25	 (1H,	 s,	 Ar‐H),	 7.65	 (3H,	m,	 Ar‐H).	 ESI‐MS	 (m/z):	 353	
[M+H]+.	Anal.	 calcd.	 for	C20H17ClN2S:	C,	68.07;	H,	4.86;	N,	7.94.	
Found:	C,	68.05;	H,	4.81;	N,	7.97%.	
2,3‐Dihydro‐2‐(2,4‐dichlorophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐
yl)‐1,5‐benzothiazepine	 (4n):	 Colour:	 Yellow.	 Yield:	 95%.	M.p.:	
118‐120	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1593	 (C=N),	 1502	 (C=C),	
1382	(C‐N),	805	(C‐Cl),	687	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	
ppm):	2.45	(3H,	s,	N‐CH3),	2.66	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐
H‐3b),	3.27	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.6	Hz,	1H,	C3‐H‐3a),	5.10	
(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.15	(1H,	s,	Ar‐H),	7.20	
(3H,	 m,	 Ar‐H),	 7.05‐7.95	 (6H,	 m,	 Ar‐H).	 ESI‐MS	 (m/z):	 388	
[M+H]+.	Anal.	calcd.	for	C20H16Cl2N2S:	C,	62.02;	H,	4.16;	N,	7.23.	
Found:	C,	62.08;	H,	4.15;	N,	7.21%.	
2,3‐Dihydro‐2‐(3‐bromophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4o):	Colour:	Yellow.	Yield:	88%.	M.p.:	139‐
141	 oC.	FT‐IR	 (KBr,	vmax,	 cm‐1):	1602	 (C=N),	1505	 (C=C),	1340	
(C‐N),	790	(C‐Br),	664	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	
2.45	(3H,	s,	N‐CH3),	2.50	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	
3.42	 (dd,	 J3a,3b	 =	14.4	Hz,	 J3a,2	 =	9.8	Hz,	1H,	C3‐H‐3a),	 4.67	 (dd,	
J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.20	(2H,	s,	Ar‐H),	7.50	(5H,	
m,	Ar‐H),	7.95‐8.68	 (4H,	m,	Ar‐H).	 ESI‐MS	 (m/z):	 398	 [M+H]+.	
Anal.	calcd.	for	C20H17BrN2S:	C,	60.46;	H,	4.31;	N,	7.05.	Found:	C,	
60.45;	H,	4.32;	N,	7.08%.	
2,3‐Dihydro‐2‐(4‐bromophenyl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4p):	Colour:	Yellow.	Yield:	92%.	M.p.:	163‐
165	 oC.	FT‐IR	 (KBr,	vmax,	 cm‐1):	1602	 (C=N),	1510	 (C=C),	1390	
(C‐N),	777	(C‐	Br),	668	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	
1.05	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	2.43	(3H,	s,	N‐CH3),	
3.44	 (dd,	 J3a,3b	 =	14.4	Hz,	 J3a,2	 =	9.4	Hz,	1H,	C3‐H‐3a),	 4.91	 (dd,	
J2,3a	=	5.3	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.15	(2H,	s,	Ar‐H),	7.20	(4H,	
m,	Ar‐H),	7.90‐8.15	 (5H,	m,	Ar‐H).	 ESI‐MS	 (m/z):	 398	 [M+H]+.	
Anal.	calcd.	for	C20H17BrN2S:	C,	60.46;	H,	4.31;	N,	7.05.	Found:	C,	
60.49;	H,	4.32;	N,	7.01%.	
2,3‐Dihydro‐2‐(2‐hydroxy‐3‐bromo‐5‐chlorophenyl)‐4‐(1‐
methyl‐1H‐pyrrol‐2‐yl)‐1,5‐benzothiazepine	 (4q):	 Colour:	
Yellow.	 Yield:	 85%.	 M.p.:	 189‐191	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	
3430	 (O‐H),	1606	 (C=N),	1508	 (C=C),	1388	 (C‐N),	802	 (C‐	Cl),	
771	(C‐	Br),	654	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	2.40	
(3H,	s,	N‐CH3),	3.39	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	4.10	
(dd,	 J3a,3b	=	14.4	Hz,	J3a,2	=	9.2	Hz,	1H,	C3‐H‐3a),	5.07	(dd,	J2,3a	=	
5.3	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	6.80	(2H,	m,	Ar‐H),6.90‐7.30	(5H,	
m,	Ar‐H),	7.10	(2H,	s,	Ar‐H),	7.99	(1H,	s,	Ar‐OH).	ESI‐MS	(m/z):	
448	[M+H]+.	Anal.	calcd.	 for	C20H16BrClN2OS:	C,	53.65;	H,	3.60;	
N,	6.26.	Found:	C,	53.62;	H,	3.65;	N,	6.21%.	
2,3‐Dihydro‐2‐(4‐allyloxyphenyl)‐4‐(1‐methyl‐1H‐pyrrol‐
2‐yl)‐1,5‐benzothiazepine	(4r):	Colour:	Yellow.	Yield:	66%.	M.p.:	
201‐203	 oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 1592	 (C=N),	 1502	 (C=C),	
1370	(C‐N),	1232	(O‐CH2),	689	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	
δ,	ppm):	2.46	(3H,	s,	N‐CH3),	3.14	(t,	 J3b,3a	=	 J3b,2	=	12.9	Hz,	1H,	
C3‐H‐3b),	3.25	 (dd,	 J3a,3b	 =	14.4	Hz,	 J3a,2	=	9.1	Hz,	1H,	C3‐H‐3a),	
4.13	(2H,	s,	‐CH2),	4.94	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	
5.10	(2H,	s,	O‐CH2),	7.15	(1H,	s,	‐CH),	7.25‐7.85	(11H,	m,	Ar‐H).		
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Table	1.	Cytotoxicity	and	antimicrobial	activity	data	of	1,5‐benzothiazepines	(4a‐v).	
Compound		 R	 Cytotoxicity	(Brine	shrimp	lethality)	 Antimicrobial	activity	a	(MIC,	µg/mL)	
Gram	+ve Gram	‐ve	 Fungi
Effective	dose	concentration	(ED50,	µg/mL)	 Bs	 Bp	 Pa	 Kp	 Ao	 Pc	
4a	 C6H5	 48.73±0.51	 128 128 256	 256	 256 256
4b	 4‐MeC6H4	 45.61±0.23	 256 256 512	 256	 128 128
4c	 4‐NMe2C6H4	 54.33±0.12	 128 64 128	 64	 128 256
4d	 3‐OMeC6H4	 53.67±0.91	 64	 64	 64	 64	 256	 256	
4e	 3,4‐diOMeC6H3	 42.31±0.41	 64	 32	 64	 64	 32	 64	
4f	 3,4,5‐triOMeC6H2	 18.92±0.33	 64	 32	 32	 32	 64	 64	
4g	 2‐OHC6H4	 59.67±0.14	 64 64 32	 64	 32 64
4h	 4‐OHC6H4	 37.18±0.12	 32 32 64	 64	 64 64
4i	 3‐OMe,4‐OHC6H3	 24.73±0.81	 256 128 128	 128	 64 32
4j	 3‐NO2C6H4	 51.82±0.37	 256 128 256	 256	 512 512
4k	 4‐NO2C6H4	 38.64±0.24	 128 128 128	 128	 128 256
4l	 4‐FC6H4	 4.17±0.12	 16 16 16	 16	 64 128
4m	 4‐ClC6H4	 22.36±0.09	 32 32 16	 16	 128 64
4n	 2,4‐diClC6H3	 14.91±0.87	 64	 64	 32	 32	 32	 32	
4o	 3‐BrC6H4	 3.93±0.42	 32	 32	 64	 32	 64	 32	
4p	 4‐BrC6H4	 16.32±0.51	 64	 64	 128	 256	 32	 64	
4q	 2‐OH,3‐Br,5‐ClC6H2	 3.45±0.15	 16 16 16	 16	 16 16
4r	 4‐Allyl‐OC6H4	 31.77±0.12	 16	 16	 32	 16	 64	 32	
4s	 Styren‐yl	 28.61±0.61	 32 64 64	 64	 128 128
4t	 Pyridin‐3‐yl	 33.47±0.23	 128 128 256	 256	 256 256
4u	 Indol‐3‐yl	 46.83±0.25	 512 512 512	 512	 512 256
4v	 Anthracen‐9‐yl	 39.12±0.12	 512 256 512	 256	 128 256
Standard	 3.31±0.15	b	 16		c 16	c 16	c	 16	c	 16	d 16	d
a	Bs:	Bacillus	 subtilis	 (NCIM	2063),	 Bp:	Bacillus	pumilus	 (NCIM	2327),	 Pa:	Pseudomonas	aeruginosa	 (NCIM	2036),	Kp:	Klebsiella	pneumonia	 (NCIM	5082),	Ao:	
Aspergillus	oryzae	(NCIM	643)	and	Pc:	Penicillium	chrysogenum	(NCIM	738).	
b	Podophyllotoxin.	
c	Chloramphenicol.	
d	Ketoconazole.	
	
	
ESI‐MS	(m/z):	375	[M+H]+.	Anal.	calcd.	for	C23H22N2OS:	C,	73.76;	
H,	5.92;	N,	7.48.	Found:	C,	73.71;	H,	5.99;	N,	7.45%.	
2,3‐Dihydro‐2‐(styren‐yl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐
benzothiazepine	(4s):	Colour:	Yellow.	Yield:	74%.	M.p.:	187‐189	
oC.	FT‐IR	(KBr,	vmax,	cm‐1):	1603	(C=N),	1514	(C=C),	1377	(C‐N),	
688	 (C‐S).	 1H	NMR	 (400	MHz,	 CDCl3,	 δ,	 ppm):	 2.43	 (3H,	 s,	 N‐
CH3),	3.38	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	3.42	(dd,	J3a,3b	=	
14.4	Hz,	J3a,2	=	9.6	Hz,	1H,	C3‐H‐3a),	4.83	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	
12	Hz,	1H,	C2‐H),	6.78	(1H,	d,	J	=	15.2	Hz,	‐CH),	7.22	(1H,	d,	J	=	
15.2	Hz,	 ‐CH),	7.37	(4H,	m,	Ar‐H),	7.69	(1H,	d,	 J	=	8	Hz,	Ar‐H),	
7.71‐7.98	 (6H,	m,	 Ar‐H),	 8.05	 (1H,	 d,	 J	 =	 8	 Hz,	 Ar‐H).	 ESI‐MS	
(m/z):	345	[M+H]+.	Anal.	calcd.	for	C22H20N2S:	C,	76.71;	H,	5.85;	
N,	8.13.	Found:	C,	76.73;	H,	5.84;	N,	8.17%.	
2,3‐Dihydro‐2‐(pyridin‐3‐yl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4t):	Colour:	Yellow.	Yield:	73%.		M.p.:	119‐
121	 oC.	FT‐IR	 (KBr,	vmax,	 cm‐1):	1599	 (C=N),	1506	 (C=C),	1382	
(C‐N),	698	(C‐S).	1H	NMR	(400	MHz,	CDCl3,	δ,	ppm):	1.07	(t,	J3b,3a	
=	J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b),	2.40	(3H,	s,	N‐CH3),	3.37	(dd,	J3a,3b	
=	14.4	Hz,	J3a,2	=	9.8	Hz,	1H,	C3‐H‐3a),	4.38	(dd,	J2,3a	=	5.3	Hz,	J2,3b	
=	12	Hz,	1H,	C2‐H),	7.25	(2H,	s,	Ar‐H),	7.30	(4H,	m,	Ar‐H),	7.75‐
8.10	(5H,	m,	Ar‐H).	ESI‐MS	(m/z):	320	[M+H]+.	Anal.	 calcd.	 for	
C19H17N3S:	C,	71.44;	H,	5.36;	N,	13.15.	Found:	C,	71.42;	H,	5.31;	
N,	13.17%.	
2,3‐Dihydro‐2‐(indol‐3‐yl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐
benzothiazepine	(4u):	Colour:	Yellow.	Yield:	81%.	M.p.:	174‐176	
oC.	 FT‐IR	 (KBr,	 vmax,	 cm‐1):	 3215	 (N‐H),	 1642	 (C=N),	 1548	
(N=O),	1510	(C=C),	1380	(C‐N),	1338	(N=O),	668	(C‐S).	1H	NMR	
(400	MHz,	CDCl3,	δ,	ppm):	2.40	(3H,	s,	N‐CH3),	3.51	(t,	J3b,3a	=	J3b,2	
=	12.9	Hz,	1H,	C3‐H‐3b),	3.74	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.9	Hz,	
1H,	C3‐H‐3a),	4.32	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	C2‐H),	7.09	
(2H,	s,	Ar‐H),	7.12	(4H,	m,	Ar‐H),	7.98‐8.10	(6H,	m,	Ar‐H),	10.5	
(1H,	 s,	 Ar‐H).	 ESI‐MS	 (m/z):	 358	 [M+H]+.	 Anal.	 calcd.	 for	
C22H19N3S:	C,	73.92;	H,	5.36;	N,	11.75.	Found:	C,	73.91;	H,	5.35;	
N,	11.71%.	
2,3‐Dihydro‐2‐(anthracen‐9‐yl)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐
1,5‐benzothiazepine	(4v):	Colour:	Yellow.	Yield:	66%.	M.p.:	201‐
203	 oC.	FT‐IR	 (KBr,	vmax,	 cm‐1):	1592	 (C=N),	1502	 (C=C),	1370	
(C‐N),	 2912	 (Ar‐CH),	 689	 (C‐S).	 1H	 NMR	 (400	MHz,	 CDCl3,	 δ,	
ppm):	2.46	(3H,	s,	N‐CH3),	3.14	(t,	J3b,3a	=	J3b,2	=	12.9	Hz,	1H,	C3‐
H‐3b),	3.25	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.1	Hz,	1H,	C3‐H‐3a),	4.94	
(dd,	 J2,3a	 =	 5.1	Hz,	 J2,3b	 =	 12	Hz,	 1H,	 C2‐H),	 6.10	 (3H,	m,	 Ar‐H),	
7.25	(2H,	s,	Ar‐H),	7.40	(6H,	m,	Ar‐H),	7.91‐7.85	(5H,	m,	Ar‐H).	
ESI‐MS	(m/z):	419	[M+H]+.	Anal.	calcd.	for	C28H22N2S:	C,	80.35;	
H,	5.30;	N,	6.69.	Found:	C,	80.31;	H,	5.32;	N,	6.65%.	
	
2.3.	Pharmacological	activity	
	
2.3.1.	Cytotoxicity	
	
The	 cytotoxicity	 potential	 of	 the	 synthesized	 compounds	
(4a‐v)	 was	 determined	 by	 Brine	 Shrimp	 Lethality	 assay	 as	
described	by	Meyer	 et	al.	 [20].	 Brine	 Shrimp	 (Artemia	 salina)	
nauplii	were	hatched	 in	sterile	brine	 solution	(prepared	using	
sea	 water	 salt	 38	 g/L	 and	 adjusted	 the	 pH	 to	 8.5	 using	 1	 N	
NaOH)	 under	 constant	 aeration	 for	 38	 h.	 After	 hatching,	 10	
nauplii	 were	 placed	 in	 each	 vial	 and	 added	 various	 concent‐
rations	of	drug	solutions	in	a	final	volume	of	5	mL,	maintained	
at	 37	 °C	 for	 24	 h	 under	 light	 of	 incandescent	 lamps	 and	
surviving	larvae	were	counted.	Each	experiment	was	conducted	
along	with	 control	 (vehicle	 treated)	 at	 various	 concentrations	
of	the	test	substances.	The	percentage	lethality	was	determined	
by	comparing	mean	surviving	 larvae	of	test	and	control	tubes.	
The	 ED50	 values	 were	 obtained	 using	 fenny	 probed	 analysis	
software.	The	result	for	the	test	compound	was	compared	with	
the	positive	control	podophyllotoxin.	The	results	of	cytotoxicity	
study	are	given	in	Table	1.	
	
2.3.2.	Antimicrobial	activity	
	
With	 respect	 to	 the	 antimicrobial	 activity,	 the	 standard	
strains	 were	 procured	 from	 the	 National	 Collection	 of	
Industrial	 Microorganisms	 (NCIM),	 National	 Chemical	
Laboratory,	 Pune,	 India.	 The	 antimicrobial	 activity	 of	 the	
synthesized	 compounds	 (4a‐v)	 was	 determined	 by	 agar	 well	
diffusion	method	as	recommended	by	the	National	Committee	
for	 Clinical	 Laboratory	 Standards,	 (NCCLS).The	 compounds	
were	 evaluated	 for	 antimicrobial	 activity	 against	 selected	
strains	 viz.	 Bacillus	 subtilis	 (NCIM	 2063),	 Bacillus	 pumilus	
(NCIM	2327),	Pseudomonas	aeruginosa	(NCIM	2036),	Klebsiella	
pneumonia	 (NCIM	 5082),	 Aspergillus	 oryzae	 (NCIM	 643)	 and	
Penicillium	 chrysogenum	 (NCIM	 738).	 Serial	 solutions	 of	
compounds	 (4a‐v)	 were	 diluted	 in	 dimethyl	 sulfoxide	 (1%	
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DMSO)	 to	 give	 a	 final	 concentration	 ranging	 from	 16	 to	 512	
µg/mL	 used	 for	 determining	 Minimum	 Inhibitory	
Concentration	(MIC)	value.	The	MIC	was	defined	as	the	lowest	
concentration	of	compound	required	for	a	complete	 inhibition	
of	 the	 bacterial	 and	 fungal	 growth	 after	 incubation	 time.	 For	
antibacterial	 activity	 nutrient	 agar	 was	 used	 seeded	 with	 0.1	
mL	 of	 the	 respective	 bacterial	 culture	 strains	 suspension	
prepared	in	a	sterile	saline	(0.85%)	of	105	CFU/mL	dilution.	For	
antifungal	activity,	different	fungal	spore	suspensions	in	sterile	
distilled	 water	 were	 adjusted	 to	 give	 a	 final	 concentration	 of	
106	CFU/mL.	An	inoculum	of	0.1	mL	spore	suspension	of	each	
fungus	was	spread	on	Potato‐Dextrose‐	Agar	(PDA)	plates.	The	
wells	 of	 6	 mm	 diameter	 were	 filled	 with	 0.1	 mL	 of	 each	
compound	having	different	concentrations	separately	 for	each	
test	 of	 bacterial	 and	 fungi	 strain.	 The	 DMSO	 (1%)	 alone	 was	
used	as	 a	 control.	The	 antibiotic	 chloramphenicol	 (16	µg/mL)	
and	 ketoconazole	 (16	 µg/mL)	 are	 used	 as	 reference	
antibacterial	and	antifungal	agents	respectively	for	comparison.	
Inoculated	plates	in	triplicate	were	then	incubated	at	37±0.5	°C	
for	 antibacterial	 activity	 for	 24	 h	 and	 48	 h	 at	 28±0.2	 °C	 for	
antifungal	activity.	After	 incubation,	 the	MICs	were	noted.	The	
results	are	given	in	Table	1	[21].	
	
3.	Results	and	discussion		
	
3.1.	Synthesis	
	
The	 titled	 compound	 4a	 was	 analysed	 for	 molecular	
formula	 C20H18N2S,	 m.p.	 125‐127	 °C,	 well	 supported	 by	 a	
[M+H]+	 at	 m/z	 319	 in	 its	 positive	 mode	 electron	 spray	
ionization	 mass	 spectrum.	 The	 FT‐IR	 spectrum	 showed	 the	
characteristic	 bands	 at	 1596	 (C=N),	 1510	 (C=C),	 1365	 (C‐N)	
and	688	(C‐S).	The	1H	NMR	spectrum	of	compound	4a	showed	
three	 characteristic	 peaks	 of	 C2‐H	 and	 C3‐CH2	 protons	 of	 1,5‐
benzothiazepine	ring	at	4.89	(dd,	J2,3a	=	5.1	Hz,	J2,3b	=	12	Hz,	1H,	
C2‐H),	3.43	(dd,	J3a,3b	=	14.4	Hz,	J3a,2	=	9.6	Hz,	1H,	C3‐H‐3a)	and	
3.36	 (t,	 J3b,3a	=	 J3b,2	=	12.9	Hz,	1H,	C3‐H‐3b).	The	spectrum	also	
showed	one	singlet	at	δ	2.50	ppm	integrating	for	three	protons	
attributed	 to	 the	 aromatic	 methyl	 group.	 The	 spectrum	 also	
accounted	for	the	other	twelve	aromatic	protons	in	between	δ	
7.25‐7.95	ppm.	The	 results	 of	 elemental	 analysis	were	 also	 in	
agreement	 with	 those	 of	 the	 calculated	 values.	 Based	 on	 the	
above	spectral	data	and	elemental	analysis,	the	structure	of	the	
compound	 4a	 was	 confirmed	 as	 2,3‐dihydro‐2‐(phenyl)‐4‐(1‐
methyl‐1H‐pyrrol‐2‐yl)‐1,5‐benzothiazepine.	 All	 the	 comp‐
ounds	 synthesized	 in	 the	 present	 study	 (4a‐4v)	 were	
characterized	 based	 on	 the	 above	 mentioned	 physical	 and	
spectroscopic	methods.	
	
3.2.	Cytotoxicity	
	
The	investigation	of	cytotoxicity	screening	data	(Table	1)	of	
all	 the	 synthesized	 1,5‐benzothiazepines	 (4a‐v)	 revealed	 that	
the	compounds	4q,	4o	and	4l	demonstrated	comparatively	the	
most	 potent	 cytotoxicity,	 with	 ED50	 values	 of	 3.45±0.15,	
3.93±0.42	 and	 4.17±0.12	 μg/mL	 respectively,	 in	 comparison	
with	 the	 standard	 drug	 (Podophyllotoxin,	 ED50	 :	 3.31	 ±	 0.17	
μg/mL).	 Structure‐Activity	 Relationship	 of	 these	 compounds	
clearly	 revealed	 the	 inherent	 cytotoxicity	 associated	with	 the	
basic	 core	 consisting	 of	 1‐methyl‐pyrrole	 and	 1,5‐benzo‐
thiazepine	 pharmacophores	 as	 displayed	 in	 case	 of	 the	
compound	4a	with	ED50	 value	of	48.73±0.51	μg/mL,	which	 in	
some	cases	was	enhanced	by	 the	 influence	of	some	 functional	
groups	 and	 decreased	 by	 some	 other	 functional	 groups	 at	
position	 2	 of	 the	 1,5‐benzothiazepinering.	 For	 example,	 the	
compounds	4q	(2‐OH,	3‐Br,	5‐Cl,	ED50:	3.45±0.15	μg/mL)	>	4o	
(3‐Br,	 ED50:	 3.93±0.42	 μg/mL)	 >	 4l	 (4‐F,	 ED50:	 4.17±0.12	
μg/mL)	>	4n	 (2,4‐di‐Cl,	 ED50:	 14.91±0.87	μg/mL)	>	4m	 (4‐Cl,	
ED50:	22.36±0.09	μg/mL)	having	halogen	substituents	either	at	
ortho	 or	 meta	 or	 para	 positions	 significantly	 enhanced	 the	
activity.	 However,	 it	 was	 revealed	 that	 various	
aromatic/heteroaromatic	rings	substituted	at	position	2	of	the	
1,5‐benzothiazepinering	 system	 followed	 its	 activity	 order	 as	
4t	(pyridine‐3‐yl,	ED50:	33.47±0.23	μg/mL)	>	4v	(anthreacen‐9‐
yl,	ED50:	39.12±0.12	μg/mL)	>	4u	(indol‐3‐yl,	ED50:	46.83±0.25	
μg/mL)	 moieties,	 respectively.	 It	 is	 also	 reported	 that	 the	
cytotoxicity	 of	 compounds	 4b‐f	 and	 4r,	 substituted	 with	
electron	releasing	groups	was	found	to	be	biologically	relevant	
and	 the	activity	order	was	4f	(3,4,5‐tri‐OMe,	ED50:	18.92±0.33	
μg/mL)	 >	 4r	 (4‐Allyl‐O,	 ED50:	 31.77±0.12)	 >	 4e	 (3,4‐diOMe,	
ED50:	42.31±0.41	μg/mL)	>	4b	(4‐Me,	ED50:	45.61±0.23	μg/mL)	
>	 4d	 (3‐OMe,	 ED50:	 53.67	 ±	 0.91	 μg/mL)>	4c	 (4‐NMe2,	 ED50:	
54.33	 ±	 0.12	 μg/mL),	 respectively.	 It	 is	 important	 that	 less	
activity	 was	 observed	 when	 the	 hydroxyl	 groups	 are	
substituted	 at	 different	 positions	 on	 the	 phenyl	 ring	 as	
displayed	 in	 the	 case	 of	 compounds	 4g	 and	4h,	 the	 order	 of	
activity	was	4h	 (4‐OH,	 ED50:	 37.18±0.12	 μg/mL)	 >	4g	 (2‐OH,	
ED50:	 59.67±0.14)	 respectively.	 It	 is	 notable	 that	 moderate	
activity	was	observed	when	the	nitro	groups	are	introduced	on	
the	phenyl	 ring	at	position	2	of	 the	1,5‐benzothiazepineringas	
displayed	in	the	case	of	compounds	4k	and	4j	with	ED50	values	
38.64±0.24	 and	 51.82±0.37	 μg/mL.	 The	 compound	 4s	 (ED50:	
28.61±0.61	 μg/mL)	 having	 phenylethylidene	 substitution	
position	 2	 of	 the	 1,5‐benzothiazepinering	 is	 also	 relevant	 for	
enhancing	the	cytotoxicity	[22].	
	
3.3.	Antimicrobial	activity	
	
The	 results	 of	 antimicrobial	 activity	 of	 the	 synthesized	
compounds	 (4a‐v)	 against	 selected	 Gram‐positive,	 Gram‐
negative	 bacteria	 and	 fungi	 are	 illustrated	 in	 Table	 1.	 Among	
the	 series	 tested,	 compounds	4q,	4r	 and	4l	were	 found	 to	be	
more	 active	 than	 other	 compounds	 with	 MIC	 16‐32	 µg/mL	
against	 all	 tested	 microorganisms.	 From	 the	 results	 of	
antibacterial	 activity,	 compound	 4r	 was	 found	 to	 be	 more	
active	 against	 all	 Gram‐positive	 bacteria	 with	 MIC	 value	 16	
µg/mL.	 Similarly,	 compound	 4l	 showed	 significant	 inhibition	
against	all	Gram‐negative	bacteria	with	MIC	16	µg/mL.	A	broad	
spectrum	 of	 antifungal	 activity	 of	 the	 compound	 4q	 was	
obtained	against	all	 the	fungi	with	MIC	16	µg/mL,	while	other	
compounds	 displayed	 relatively	 less	 antifungal	 activity.	 From	
the	 activity	 data	 of	 compounds	 4a‐4v,	 the	 following	
conclusions	can	be	made	with	respect	to	their	structure‐activity	
relationship:	 the	 degree	 of	 antimicrobial	 (antibacterial	 and	
antifungal)	 activity	 may	 be	 varied	 with	 their	 corresponding	
substituents	at	2	of	the	1,5‐benzothiazepinering.	A	remarkable	
reduction	in	the	antimicrobial	activity	was	observed	when	the	
substituted	 phenyl	 ring	 at	 position	 2	 of	 the	 1,5‐benzothiaze‐
pinering	 is	 replaced	 with	 other	 aromatic	 or	 heteroaromatic	
rings	 as	 displayed	 in	 case	 of	 compounds	4a	 and	4t‐v	 and	 its	
order	 is	 phenyl	 >	 pyridin‐3‐yl	 >	 anthracene‐9‐yl	 >	 indol‐3‐yl,	
respectively.	 The	 substituted	 phenyl	 ring	 of	 the	 1,5‐benzo	
thiazepineat	position	2further	substituted	with	halogens	either	
at	ortho,	meta	or	para	positions	correspondingly	enhanced	the	
antibacterial	activity	(4q	(2‐OH,	3‐Br,	5‐Cl)	>	4l	(4‐F)	>	4o	(3‐
Br)	 >	 4m	 (4‐Cl)	 >	 4p	 (4‐Br))	 as	 displayed	 in	 the	 case	 of	
compounds	 4l‐4q.	 It	 is	 noteworthy	 that	 compounds	 having	
electron	donating	 substituents	 (3,4,5‐tri‐OCH3	 >	3,4‐di‐OCH3	 >	
3‐OCH3	 >	 4‐N(CH3)2	 >	 4‐CH3)	 on	 the	 phenyl	 ring	 of	 1,5‐
benzothiazepine	at	ortho,	meta	and	para	positions	was	found	to	
enhance	the	antibacterial	activity.	An	increase	in	the	antifungal	
activity	 was	 also	 observed	 for	 the	 compounds	 4l‐q	 having	
halogen	 substitution	 but	 the	 degree	 of	 activity	 in	most	 of	 the	
cases	 is	found	to	be	 less	than	that	of	 the	antibacterial	activity.	
The	 compounds	 4g	 and	 4h	 having	 hydroxyl	 group	 either	 at	
ortho	 or	 para	 position	 also	 contributed	 favourably	 to	 the	
antifungal	activity.	 Similarly,	 the	presence	of	allyloxy	group	at	
the	 para	 position	 of	 the	 phenyl	 ring	 as	 displayed	 in	 case	 of	
compound	 4r	 also	 enhanced	 the	 antibacterial	 activity.	 A	
decrease	in	the	antifungal	activity	is	attributed	to	the	presence	
of	 nitro	 group	 on	 the	 phenyl	 ring	 at	 ortho	 or	meta	 or	 para	
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positions	 as	 displayed	 in	 the	 case	 of	 compounds	 4j	 and	 4k	
[23,24].	
	
4.	Conclusion	
	
In	conclusion,	we	have	developed	a	series	of	some	new	2,3‐
dihydro‐2‐(susbtituted)‐4‐(1‐methyl‐1H‐pyrrol‐2‐yl)‐1,5‐
benzothiazepines	 (4a‐v).	 In	 the	 present	 study	 proposed	
method	has	advantage	over	existing	conventional	method	with	
high	yield	and	shorter	reaction	time.	This	procedure	represents	
a	 convenient,	 economic	and	environmentally	 friendly	process.	
These	 compounds	 were	 screened	 for	 cytotoxic	 and	
antimicrobial	 activities.	 It	 was	 observed	 from	 the	 results	
obtained	that	most	of	the	tested	compounds	showed	significant	
cytotoxic	 and	 antimicrobial	 activities	 and	 it	 could	 be	 a	
remarkable	preliminary	 confirmation	 to	develop	new	 leads	 in	
fight	against	cancer	and	microbial	infections.	The	cytotoxic	and	
antimicrobial	 activities	 data	 revealed	 that	 the	 synergistic	
nature	 of	 1‐methylpyrrole	 and	 1,5‐benzothiazepine	
heterocyclic	 ring	 systems	 which	 forming	 part	 of	 the	 basic	
nucleus.	 The	 observed	 activities	 may	 also	 be	 due	 to	 the	
substitution	at	position	2	on	the	1,5‐benzothiazepine	ring.	
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